Breast cancer patients with early stage disease may not benefit from radiation after mastectomy (News-Medical-Net)

Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D …

Read the rest here:
Breast cancer patients with early stage disease may not benefit from radiation after mastectomy (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

Night Read (Ohio): Fluence Therapeutics opens in Akron (MedCity News)

News and notes from the day in MedCity, Ohio: University Hospitals Case Medical Center’s first spinoff company Fluence Therapeutics Inc. recently opened in the downtown Akron Global Business Accelerator on South Main Street, the Akron Beacon Journal reported. The start-up comes from more than 20 years of research on a psoriasis treatment known as photodynamic therapy

Read more from the original source:
Night Read (Ohio): Fluence Therapeutics opens in Akron (MedCity News)

----------------------------------------------------------------------------------------------------------------------------------------------------

Two more H1N1 flu shot clinics planned by Salem County Department …

The largest ever trial to find a treatment for potentially fatal peanut allergies is to give sufferers tiny amounts daily to build up tolerance. Cambridge University researchers will give increasing doses of peanut flour to 104 British …

Go here to read the rest:
Two more H1N1 flu shot clinics planned by Salem County Department …

----------------------------------------------------------------------------------------------------------------------------------------------------

Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit in Preventing … (Marketwire)

AMARILLO, TX–(Marketwire – February 16, 2010) – Amarillo Biosciences, Inc. (ABI) ( OTCBB : AMAR ) today announced additional preliminary results from the recently completed Phase 2 clinical trial conducted in Perth, Australia at the University of Western Australia with Professors David Smith and Manfred Beilharz as principal investigators.

Here is the original post:
Amarillo Biosciences Announces Australian Phase 2 Oral Interferon Clinical Trial Indicates Benefit in Preventing … (Marketwire)

----------------------------------------------------------------------------------------------------------------------------------------------------

NanoViricides Announces a Research Agreement With Leading Dengue Virus Researcher at the University of California … (Business Wire via Yahoo!…

WEST HAVEN, Conn.—-NanoViricides, Inc. , reports that it has signed a research and development agreement with Dr. Eva Harris’s laboratory at the University of California, Berkeley .

Excerpt from:
NanoViricides Announces a Research Agreement With Leading Dengue Virus Researcher at the University of California … (Business Wire via Yahoo!…

----------------------------------------------------------------------------------------------------------------------------------------------------

Tobacco users with HPV-positive head and neck cancers at increased risk of recurrence (News-Medical-Net)

Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

Excerpt from:
Tobacco users with HPV-positive head and neck cancers at increased risk of recurrence (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

Researcher receives $2.4M grant from NIH to study preeclampsia and diabetes in pregnant women (News-Medical-Net)

The link between obesity and high-risk pregnancies caused by preeclampsia and diabetes will be the focus of a $2.4 million National Institutes of Health research grant received by Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston.

More here:
Researcher receives $2.4M grant from NIH to study preeclampsia and diabetes in pregnant women (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

Diabetic retinopathy: 5.3M U.S adults suffer (News-Medical-Net)

Despite major progress in diagnosis and treatment, diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S., said Thomas C. Lee, director, Retina Institute in The Vision Center at Childrens Hospital Los Angeles, associate professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California and attending physician at Doheny …

View original post here:
Diabetic retinopathy: 5.3M U.S adults suffer (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------

H1N1 v seasonal flu. « Team McCallum

The recent findings of Dr Ryan Zarychanski of the University of Manitoba, that surviving H1N1 influenza requires seeking treatment early, may also benefit from this advice on prevention of transmission in H1N1 . …

Read this article:
H1N1 v seasonal flu. « Team McCallum

----------------------------------------------------------------------------------------------------------------------------------------------------

Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys’ summer camp (News-Medical-Net)

Providing preventive Tamiflu and educating and emphasizing the need for repeated hand sanitizer use and disinfectant spray helped stop the spread of H1N1 influenza at a boys’ summer camp in northern Alabama, according the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

Excerpt from:
Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys’ summer camp (News-Medical-Net)

----------------------------------------------------------------------------------------------------------------------------------------------------